Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.

Survival analysis anticipates the expected lifespans of individuals as well as the timing of other events. Learn about its pros and cons.

Anthropic's Claude Opus 4.6 surfaced 500+ high-severity vulnerabilities that survived decades of expert review. Fifteen days later, they shipped Claude Code Security. Here's what reasoning-based ...

The resulting outcome is that you have A.I. systems that have learned what it means to solve a problem that takes quite a while and requires them running into dead ends and needing to reset themselves ...